Erythropoiesis and Myocardial Energy Requirements Contribute to the Hypermetabolism of Childhood Sickle Cell Anemia
Overview
Authors
Affiliations
Objectives: We hypothesized that an elevated hemoglobin synthesis rate (SynHb) and myocardial oxygen consumption (MVO2) contribute to the excess protein and energy metabolism reported in children with sickle cell anemia.
Patients And Methods: Twelve children (6-12 years old) with asymptomatic sickle cell and 9 healthy children matched for age and sex were studied. Measurements were whole-body protein turnover by [1-C]leucine, SynHb by [N]glycine, resting energy expenditure by indirect calorimetry and the systolic blood pressure-heart rate product used as an index of MVO2. Protein energy cost was calculated from protein turnover. Statistical analysis included Spearman correlations and partial correlation analyses.
Results: Although body mass index was significantly lower for sickle cell versus controls (P < 0.02), children with asymptomatic sickle cell had 52% higher protein turnover (P < 0.0005). Proportional reticulocyte count, SynHb, MVO2 and resting energy expenditure were also significantly higher in children with sickle cell (P < 0.01). Protein turnover correlated significantly with both SynHb (r = 0.63, P < 0.01) and reticulocyte percentage (r = 0.83, P < 0.0001). Partial correlation of these 3 variables showed reticulocyte percentage as the only variable to be significantly associated with protein turnover, even after adjusting for sickle cell anemia (P = 0.03). Partial correlation of log resting energy expenditure on MVO2 was significant, controlling for protein energy cost, sex and age (P = 0.03).
Conclusion: These results indicate that metabolic demands of increased erythropoiesis and cardiac energy consumption account for much of the excess protein and energy metabolism in children with sickle cell anemia.
Influence of hydroxyurea on tubular phosphate handling in sickle cell nephropathy.
de Abreu G, de Sousa D, Carvalho Dantas S, Martins A, Sampaio T, Goncalves Lemes R Hematol Transfus Cell Ther. 2024; 46 Suppl 5:S163-S169.
PMID: 38485550 PMC: 11670720. DOI: 10.1016/j.htct.2023.11.015.
Ritter C, Abdullahi S, Gambo S, Murtala H, Kabir H, Shamsu K BMC Nutr. 2024; 10(1):18.
PMID: 38268013 PMC: 10809526. DOI: 10.1186/s40795-024-00826-0.
Incorporating gonadal health counseling into pediatric care of sickle cell patients.
Meacham L, Pecker L, Gee B, Mishkin A Hematology Am Soc Hematol Educ Program. 2022; 2022(1):442-449.
PMID: 36485118 PMC: 9820063. DOI: 10.1182/hematology.2022000382.
Penkert R, Azul M, Sealy R, Jones B, Dowdy J, Hayden R Nutrients. 2022; 14(16).
PMID: 36014920 PMC: 9414848. DOI: 10.3390/nu14163415.
Nutritional perspectives on sickle cell disease in Africa: a systematic review.
Nartey E, Spector J, Adu-Afarwuah S, Jones C, Jackson A, Ohemeng A BMC Nutr. 2021; 7(1):9.
PMID: 33731225 PMC: 7972183. DOI: 10.1186/s40795-021-00410-w.